Skip to main content
. 2020 May 8;2020(5):CD012419. doi: 10.1002/14651858.CD012419.pub2

NCT03156348.

Methods RCT (3 groups)
Participants Inclusion: patients 60 years or older attended by the staff of internists of the internal medicine service of the Clinical Hospital of the University of Chile for acute condition or decompensation of chronic pathology; with estimated survival > 6 months; on pharmacological therapy; having a contact person or responsible caregiver willing to comply with the scheduled care plan; and having a contact telephone number
Exclusion: cognitive impairment and no caregiver, any other condition that in the judgement of the research team affects the quality of the collection of information
Interventions Intervention: during hospitalisation and at discharge, a clinical pharmacist (CP) will monitor daily pharmacological safety and efficacy of the medication to assess and make appropriate recommendations. CP will explain the reasons for use of each of the drugs. At 30 days post discharge, CP will review the updated clinical record of the patient and will conduct a home visit to enhance and ask about adherence, self‐medication, medication use at that time, and possible results of laboratory tests performed and to clarify doubts regarding the use of current medications. The same activities will be conducted at 60 days by telephonic way, to reinforce the recommendations
Parallel control: usual care by team with training on pharmacogeriatrics
Historical control group: usual care (no training)
Outcomes Adherence measured with Morisky and Green scale, adverse drug events, hospitalisations, prevalence of self‐medication (taking a drug without medical indications)
Notes NCT03156348
Start date: May 2015. Estimated completion: December 2017
Investigators contacted for more information (email: comiteetica@hcuch.cl) ‐ no response
Note: need to determine mean/median number of medications to confirm eligibility